Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
0.9901
-0.0048 (-0.48%)
At close: Jun 15, 2026, 4:00 PM EDT
1.010
+0.020 (2.01%)
After-hours: Jun 15, 2026, 4:43 PM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $13.65 million as of June 15, 2026. Its market cap has decreased by -21.55% in one year.
Market Cap
13.65M
Enterprise Value
10.46M
1-Year Change
-21.55%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $13.65M, a decrease of -88.16%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 13.65M | 1.12% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Citius Pharmaceuticals | 14.82M |
| BioLineRx | 14.37M |
| Moleculin Biotech | 14.09M |
| IN8bio | 14.08M |
| Theriva Biologics | 13.94M |
| Cyclerion Therapeutics | 13.78M |
| CalciMedica | 13.65M |
| CytoMed Therapeutics | 13.49M |